Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Other Operating Expenses (2014 - 2026)

Updated

Theravance Biopharma (TBPH) reported Other Operating Expenses of $6.09 million for Q2 2026.

Analysis

Theravance Biopharma (TBPH) Other Operating Expenses (2014 - 2026) Analysis & Trends

For FY2024, Theravance Biopharma posted Other Operating Expenses of $4.51 million.

  • The Q2 2026 figure ranks as the highest quarterly Other Operating Expenses in data going back to Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.09 Mn
Dec 31, 2025 -1,000.00
Sep 30, 2024 1.56 Mn
Jun 30, 2024 2.95 Mn
Dec 31, 2022 1,000.00
Sep 30, 2022 -5.06 Mn
Jun 30, 2022 3.78 Mn
Mar 31, 2022 1.28 Mn
Dec 31, 2020 130,000.00
Dec 31, 2018 632,000.00
Sep 30, 2018 705,000.00
Jun 30, 2018 -1.45 Mn
Mar 31, 2018 826,000.00
Dec 31, 2017 3.12 Mn
Sep 30, 2017 985,000.00
Jun 30, 2017 1.36 Mn
Mar 31, 2017 565,000.00
Dec 31, 2016 1.15 Mn
Sep 30, 2016 332,000.00
Jun 30, 2016 638,000.00
API Access

Theravance Biopharma Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=TBPH&period=max&api_key=YOUR_API_KEY